About Us

We are a vertically integrated biotechnology company dedicated to delivering the promise of radiopharmaceuticals to patients. Over the last 20 years, we have developed our business to encompass every stage of the process: beginning with the production of radioisotopes and expanding to develop our own radiopharmaceuticals for diagnosis and treatment.

We are also expanding our capabilities in the manufacture and supply of novel radioisotopes, and we are growing our ability to produce and supply new types of radioisotopes, advancing our position as a leading global supplier of n.c.a. Lutetium (Lu-177) and Actinium-225 (Ac-225).